NCT03329378 2023-08-22Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast CancerIcahn School of Medicine at Mount SinaiPhase 2 Terminated7 enrolled 10 charts
NCT01660542 2016-11-01An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerYonsei UniversityPhase 4 Completed96 enrolled